Cargando…
Effects of Introducing Xpert MTB/RIF on Diagnosis and Treatment of Drug-Resistant Tuberculosis Patients in Indonesia: A Pre-Post Intervention Study
BACKGROUND: In March 2012, the Xpert MTB/RIF assay (Xpert) was introduced in three provincial public hospitals in Indonesia as a novel diagnostic to detect tuberculosis and rifampicin resistance among high risk individuals. OBJECTIVE: This study assessed the effects of using Xpert in place of conven...
Autores principales: | van Kampen, Sanne C., Susanto, Nugroho H., Simon, Sumanto, Astiti, Shinta D., Chandra, Roni, Burhan, Erlina, Farid, Muhammad N., Chittenden, Kendra, Mustikawati, Dyah E., Alisjahbana, Bachti |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4468115/ https://www.ncbi.nlm.nih.gov/pubmed/26075722 http://dx.doi.org/10.1371/journal.pone.0123536 |
Ejemplares similares
-
Performance of Xpert MTB/RIF and sputum microscopy compared to sputum culture for diagnosis of tuberculosis in seven hospitals in Indonesia
por: Karuniawati, Anis, et al.
Publicado: (2023) -
Evaluation of Xpert MTB-RIF guided diagnosis and treatment of rifampicin-resistant tuberculosis in Indonesia: A retrospective cohort study
por: Soeroto, Arto Yuwono, et al.
Publicado: (2019) -
Using Xpert MTB/RIF
por: Nicol, Mark P., et al.
Publicado: (2013) -
Xpert MTB/RIF and Xpert MTB/RIF Ultra for pulmonary tuberculosis and rifampicin resistance in adults
por: Horne, David J, et al.
Publicado: (2019) -
Xpert MTB/RIF Ultra and Xpert MTB/RIF assays for extrapulmonary tuberculosis and rifampicin resistance in adults
por: Kohli, Mikashmi, et al.
Publicado: (2021)